Davunetide (AL-108) in Predicted Tauopathies - Pilot Study

Clinical trial NCT01056965 · COMPLETED

Trial details

NCT number: NCT01056965
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Predicted Tauopathies, Including Progressive Supranuclear Palsy Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17 Corticobasal Degeneration Syndrome Progressive Nonfluent Aphasia

Start date: 2010-01-01
Primary completion: 2012-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.